Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27724067 | 0.86 | OPRM1 (0.37) | OPRM1SPHK1 | |
| Ammonia Solution, Strong SCHEMBL8352036 | 0.86 | OPRM1 (0.37) | OPRM1SPHK1 | |
| Ammonia Solution, Strong SCHEMBL766319 | 0.86 | FDPS (0.33) | SPHK1 | |
| Ammonia Solution, Strong SCHEMBL2548500 | 0.85 | — | — | |
| Ammonia Solution, Strong SCHEMBL2260150 | 0.83 | LMNA (0.41) | — | |
| Ammonia Solution, Strong SCHEMBL1334487 | 0.83 | LMNA (0.41) | — | |
| Ammonia Solution, Strong SCHEMBL537607 | 0.83 | LMNA (0.41) | — | |
| Ammonia Solution, Strong SCHEMBL213749 | 0.83 | LMNA (0.41) | — | |
| Ammonia Solution, Strong SCHEMBL1133459 | 0.83 | LMNA (0.41) | — | |
| Ammonia Solution, Strong SCHEMBL1333866 | 0.83 | LMNA (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050147655-A1 | Elastomers; exterior surfaces containing quaternized organosilicon polymer; antimicrobial material should remain durably attached on the surface and retain its biocidal effectiveness for at least 48 hours from time of first exposure or use | BAGWELL ALISON S (US) | 2005-07-07 | — | — | US | claimed |
| US-4842766-A | Silane microemulsions | DOW CORNING CORPORATION (US) | 1989-06-27 | — | — | US | claimed |
| US-20060134163-A1 | Immobilizing anti-microbial compounds on elastomeric articles | KIMBERLY-CLARK WORLDWIDE, INC. | 2006-06-22 | — | — | US | disclosed |
| EP-0279623-B1 | SILANE MICROEMULSIONS | DOW CORNING CORPORATION (US) | 1993-07-14 | — | — | EP | disclosed |
| US-4842766-A | Silane microemulsions | DOW CORNING CORPORATION (US) | 1989-06-27 | — | — | US | disclosed |
| EP-0279623-A2 | Silane microemulsions | DOW CORNING CORPORATION (US) | 1988-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060134163-A1 | Immobilizing anti-microbial compounds on elastomeric articles | LPO, MPO, PCNA | OPRM1 2640/4885SPHK1 3636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.